MEP39208A - USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION - Google Patents
USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATIONInfo
- Publication number
- MEP39208A MEP39208A MEP-392/08A MEP39208A MEP39208A ME P39208 A MEP39208 A ME P39208A ME P39208 A MEP39208 A ME P39208A ME P39208 A MEP39208 A ME P39208A
- Authority
- ME
- Montenegro
- Prior art keywords
- hcg
- ovarian hyperstimulation
- controlled ovarian
- controlled
- hyperstimulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01307757 | 2001-09-12 | ||
| PCT/GB2002/004158 WO2003022302A2 (en) | 2001-09-12 | 2002-09-12 | USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MEP39208A true MEP39208A (en) | 2011-02-10 |
Family
ID=8182261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-392/08A MEP39208A (en) | 2001-09-12 | 2002-09-12 | USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7405197B2 (zh) |
| EP (1) | EP1425032A2 (zh) |
| JP (1) | JP2005501918A (zh) |
| KR (1) | KR20040032954A (zh) |
| CN (1) | CN100536912C (zh) |
| AR (1) | AR036592A1 (zh) |
| BR (1) | BR0212429A (zh) |
| CA (1) | CA2457849A1 (zh) |
| EA (1) | EA009330B1 (zh) |
| HK (1) | HK1067867A1 (zh) |
| HR (1) | HRP20040087A2 (zh) |
| IL (1) | IL160780A0 (zh) |
| ME (1) | MEP39208A (zh) |
| MX (1) | MXPA04002256A (zh) |
| NO (1) | NO20040991L (zh) |
| PL (1) | PL369098A1 (zh) |
| RS (1) | RS21004A (zh) |
| UA (1) | UA82650C2 (zh) |
| WO (1) | WO2003022302A2 (zh) |
| ZA (1) | ZA200400835B (zh) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE416783T1 (de) * | 2003-02-07 | 2008-12-15 | Austria Wirtschaftsserv Gmbh | Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen |
| US20040248784A1 (en) | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
| US20150273020A1 (en) * | 2007-05-11 | 2015-10-01 | Lori R. Bernstein | Hormone Normalization Therapy and Uses Therefor |
| EP2243423B1 (de) * | 2009-04-23 | 2012-05-02 | Roche Diagnostics GmbH | Verfahren und Gerät zur Ermittlung von Empfehlungen für Wirkstoffdosierungen anhand von Messserien zumindest eines physiologischen Parameters eines Patienten |
| TWI532495B (zh) | 2009-10-05 | 2016-05-11 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
| CN103619358B (zh) | 2011-03-31 | 2017-02-15 | 辉凌公司 | 药物制剂 |
| US8680086B2 (en) | 2011-04-15 | 2014-03-25 | Neuralight Hd, Llc | Methods for chronic pain management and treatment using HCG |
| US20120265129A1 (en) * | 2011-04-15 | 2012-10-18 | Neuralight Hd, Llc | Methods for Chronic Pain Management and Treatment using HCG |
| RU2014103185A (ru) | 2011-07-18 | 2015-08-27 | Артс Байолоджикс А/С | Биологически активное соединение на основе лютеинизирующего гормона (lh) с пролонгированным действием |
| US10271876B2 (en) | 2011-11-23 | 2019-04-30 | Mezadata Medical Ip Holding Llc | Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells |
| WO2014063071A1 (en) | 2012-10-18 | 2014-04-24 | Neuralight Hd, Llc | Treatment of depression and ptsd |
| WO2014159813A1 (en) | 2013-03-13 | 2014-10-02 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| CA3031252A1 (en) | 2016-07-21 | 2018-01-25 | ObsEva S.A. | Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage |
| CA3035055A1 (en) | 2016-08-29 | 2018-03-08 | Progena, Inc. | Autologous somatic stem cell therapy, method of controllable preparation of therapeutic composition and procedure of adaptive treatment of ivf patient |
| RU2646578C1 (ru) * | 2017-02-13 | 2018-03-05 | Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) | Способ повышения эффективности имплантации эмбриона в естественном цикле зачатия и в протоколах вспомогательных репродуктивных технологий |
| CN109431647B (zh) * | 2018-09-20 | 2020-10-30 | 华中农业大学 | 一种杂交水牛同期发情-定时输精的处理方法 |
| EP4025207A1 (en) | 2019-09-03 | 2022-07-13 | ObsEva S.A. | Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage |
| US20230102503A1 (en) | 2020-02-10 | 2023-03-30 | ObsEva S.A. | Biomarkers for oxytocin receptor antagonist therapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4589402A (en) | 1984-07-26 | 1986-05-20 | Serono Laboratories, Inc. | Method of in vitro fertilization |
| US5705478A (en) * | 1989-02-21 | 1998-01-06 | Washington University | Covalently linked β subunits of the glycoprotein hormones as antagonists |
| ES2247710T3 (es) | 1997-06-20 | 2006-03-01 | Akzo Nobel N.V. | Antagonista de gonadotropina. |
| ZA987497B (en) | 1997-09-08 | 1999-02-23 | Akzo Nobel Nv | Expression of gonadotropins in dictyostelium |
| US6090848A (en) * | 1997-12-01 | 2000-07-18 | Sigma-Tau Healthscience S.P.A. | Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
| KR20010093280A (ko) * | 1999-02-24 | 2001-10-27 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | 불임증 치료 |
| CN1352566A (zh) * | 1999-05-07 | 2002-06-05 | 应用研究系统Ars股份公司 | 促性腺激素 |
| PT1250148E (pt) | 2000-01-27 | 2004-09-30 | Applied Research Systems | Uso de fsh para o tratamento da infertilidade |
-
2002
- 2002-09-12 EA EA200400427A patent/EA009330B1/ru not_active IP Right Cessation
- 2002-09-12 BR BR0212429-7A patent/BR0212429A/pt not_active IP Right Cessation
- 2002-09-12 US US10/489,220 patent/US7405197B2/en not_active Expired - Fee Related
- 2002-09-12 JP JP2003526430A patent/JP2005501918A/ja active Pending
- 2002-09-12 ME MEP-392/08A patent/MEP39208A/xx unknown
- 2002-09-12 KR KR10-2004-7002590A patent/KR20040032954A/ko not_active Application Discontinuation
- 2002-09-12 IL IL16078002A patent/IL160780A0/xx unknown
- 2002-09-12 CA CA002457849A patent/CA2457849A1/en not_active Abandoned
- 2002-09-12 MX MXPA04002256A patent/MXPA04002256A/es not_active Application Discontinuation
- 2002-09-12 PL PL02369098A patent/PL369098A1/xx unknown
- 2002-09-12 WO PCT/GB2002/004158 patent/WO2003022302A2/en not_active Application Discontinuation
- 2002-09-12 AR ARP020103456A patent/AR036592A1/es unknown
- 2002-09-12 CN CNB028175735A patent/CN100536912C/zh not_active Expired - Fee Related
- 2002-09-12 EP EP02758598A patent/EP1425032A2/en not_active Withdrawn
- 2002-09-12 RS YU21004A patent/RS21004A/sr unknown
- 2002-12-09 UA UA2004031860A patent/UA82650C2/uk unknown
-
2004
- 2004-01-28 HR HRP20040087 patent/HRP20040087A2/xx not_active Application Discontinuation
- 2004-02-02 ZA ZA2004/00835A patent/ZA200400835B/en unknown
- 2004-03-08 NO NO20040991A patent/NO20040991L/no not_active Application Discontinuation
-
2005
- 2005-02-22 HK HK05101454.2A patent/HK1067867A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EA200400427A1 (ru) | 2004-08-26 |
| NO20040991L (no) | 2004-03-08 |
| CN100536912C (zh) | 2009-09-09 |
| AR036592A1 (es) | 2004-09-22 |
| US7405197B2 (en) | 2008-07-29 |
| WO2003022302A2 (en) | 2003-03-20 |
| HK1067867A1 (en) | 2005-04-22 |
| EA009330B1 (ru) | 2007-12-28 |
| WO2003022302A3 (en) | 2003-12-18 |
| UA82650C2 (uk) | 2008-05-12 |
| ZA200400835B (en) | 2005-04-26 |
| US20050065069A1 (en) | 2005-03-24 |
| JP2005501918A (ja) | 2005-01-20 |
| IL160780A0 (en) | 2004-08-31 |
| EP1425032A2 (en) | 2004-06-09 |
| KR20040032954A (ko) | 2004-04-17 |
| PL369098A1 (en) | 2005-04-18 |
| CA2457849A1 (en) | 2003-03-20 |
| HRP20040087A2 (en) | 2004-12-31 |
| CN1553808A (zh) | 2004-12-08 |
| BR0212429A (pt) | 2004-10-26 |
| RS21004A (en) | 2006-12-15 |
| MXPA04002256A (es) | 2004-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP39208A (en) | USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION | |
| SE0100901D0 (sv) | New composition | |
| HK1067865A1 (en) | Use of hcg and lh in controlled ovarian hyperstimulation | |
| MXPA02004666A (es) | Gelatinas recombinantes. | |
| MX348356B (es) | Metodo y dispositivo para sintetizar un oxidante y aplicaciones del mismo. | |
| IL156774A0 (en) | Inhibitors of cruzipain and other cysteine proteases | |
| DE60312222D1 (de) | Haarbehandlungsmittel enthaltend climbazole | |
| MXPA03007140A (es) | Derivados de carbolina. | |
| MXPA02011288A (es) | Tioacetamidas substituidas. | |
| CY1108446T1 (el) | Μη νευροτοξικοι παραγοντες ενεργοποιησης πλασμινογονου για την αντιμετωπιση αποπληξιας | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| ATE430403T1 (de) | Synchronisierter gesteuerter oszillationsmodulator | |
| ATE358738T1 (de) | Gewebe | |
| DE60135778D1 (de) | Okklusionsvorrichtung | |
| NO20040990L (no) | Andvendelse av LH i kontrollert ovariehyperstimulering. | |
| WO2002057246A3 (en) | Inhibitors of cruzipain and other cysteine proteases | |
| DK1274426T3 (da) | Anvendelse af thioamidoxazolidinoner til behandling af knogleresorption og osteoporose | |
| DK1224166T3 (da) | Fremgangsmåde til fremstilling af N-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin-hydrochlorid | |
| DE60236756D1 (de) | Kombinieren von schmalbandanwendungen mit breitbandtransport | |
| DK1368478T3 (da) | Polypeptid, der fremkalder HIV-neutraliserende antistoffer | |
| MXPA04004526A (es) | N-metil-homocisteinas, su uso y metodo para su produccion. | |
| WO2002057248A3 (en) | Inhibitors of cruzipain and other cysteine proteases | |
| DE60239829D1 (de) | Kombinieren von schmalbandanwendungen mit breitbandtransport | |
| DE60220699D1 (de) | Tibolonformulierungen | |
| ATE370070T1 (de) | Flasche |